-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
What Does Jinxin Fertility Group Limited's (HKG:1951) Share Price Indicate?
What Does Jinxin Fertility Group Limited's (HKG:1951) Share Price Indicate?
Jinxin Fertility Group Limited (HKG:1951), might not be a large cap stock, but it received a lot of attention from a substantial price movement on the SEHK over the last few months, increasing to HK$7.26 at one point, and dropping to the lows of HK$4.99. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Jinxin Fertility Group's current trading price of HK$5.19 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at Jinxin Fertility Group's outlook and value based on the most recent financial data to see if there are any catalysts for a price change.
Check out our latest analysis for Jinxin Fertility Group
What Is Jinxin Fertility Group Worth?
Jinxin Fertility Group appears to be expensive according to my price multiple model, which makes a comparison between the company's price-to-earnings ratio and the industry average. In this instance, I've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. I find that Jinxin Fertility Group's ratio of 33.54x is above its peer average of 16.86x, which suggests the stock is trading at a higher price compared to the Healthcare industry. If you like the stock, you may want to keep an eye out for a potential price decline in the future. Since Jinxin Fertility Group's share price is quite volatile, this could mean it can sink lower (or rise even further) in the future, giving us another chance to invest. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.
Can we expect growth from Jinxin Fertility Group?
SEHK:1951 Earnings and Revenue Growth August 23rd 2022Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. Jinxin Fertility Group's earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value.
What This Means For You
Are you a shareholder? It seems like the market has well and truly priced in 1951's positive outlook, with shares trading above industry price multiples. At this current price, shareholders may be asking a different question – should I sell? If you believe 1951 should trade below its current price, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.
Are you a potential investor? If you've been keeping tabs on 1951 for some time, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the optimistic prospect is encouraging for 1951, which means it's worth diving deeper into other factors in order to take advantage of the next price drop.
Diving deeper into the forecasts for Jinxin Fertility Group mentioned earlier will help you understand how analysts view the stock going forward. So feel free to check out our free graph representing analyst forecasts.
If you are no longer interested in Jinxin Fertility Group, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
金鑫生育集团有限公司(HKG:1951)可能不是一只大盘股,但它受到了过去几个月联交所价格大幅波动的极大关注,一度涨至7.26港元,并跌至4.99港元的低点。一些股价波动可以让投资者有更好的机会买入股票,并有可能以更低的价格买入。一个需要回答的问题是,金鑫生育集团目前5.19港元的交易价是否反映了小盘股的实际价值?或者,它目前被低估了,为我们提供了买入的机会?让我们根据最新的财务数据来看看金鑫生育集团的前景和价值,看看是否有任何推动价格变化的催化剂。
查看我们对金鑫生育集团的最新分析
金鑫生育集团值多少钱?
根据我的市盈率模型,金鑫生育集团似乎很贵,该模型将该公司的市盈率与行业平均水平进行了比较。在这种情况下,考虑到没有足够的信息来可靠地预测股票的现金流,我使用了市盈率(PE)。我发现,金鑫生育集团的市盈率为33.54倍,高于16.86倍的同行平均水平,这表明该股的股价高于医疗行业。如果你喜欢这只股票,你可能想要密切关注未来可能的价格下跌。由于金鑫生育集团的股价波动很大,这可能意味着它未来可能会下跌(或进一步上涨),给我们另一个投资机会。这是基于其较高的贝塔系数,这是衡量该股相对于市场其他股票波动程度的一个很好的指标。
我们能期待金鑫生育集团的增长吗?
联交所:1951年盈利及收入增长2022年8月23日寻求投资组合增长的投资者可能希望在购买一家公司的股票之前考虑其前景。以低廉的价格收购一家前景稳健的伟大公司永远是一笔不错的投资,所以让我们也来看看该公司的未来预期。金鑫生育集团未来几年的盈利预计将翻一番,预示着非常乐观的未来。这应该会带来更强劲的现金流,从而推动更高的股价。
这对你意味着什么
你是股东吗?市场似乎已经很好地、真实地反映了1951年的乐观前景,股价高于行业市盈率。在目前的价格下,股东们可能会问一个不同的问题--我应该卖出吗?如果你认为1951应该在当前价格以下交易,那么当其价格跌至行业水平时,逢高抛售并再次买入,市盈率可能是有利可图的。但在你做出这个决定之前,先看看它的基本面是否发生了变化。
你是潜在的投资者吗?如果你关注1951年已经有一段时间了,现在可能不是买入这只股票的最佳时机。这一价格已经超过了业内同行,这意味着错误定价很可能不会带来更多的好处。然而,乐观的前景对1951年来说是令人鼓舞的,这意味着为了利用下一次价格下跌,值得更深入地研究其他因素。
深入研究前面提到的对金鑫生育集团的预测,将有助于你了解分析师对该股未来的看法。因此,请随时查看我们代表分析师预测的免费图表。
如果你对金鑫生育集团不再感兴趣,你可以使用我们的免费平台查看我们的50多只其他具有高增长潜力的股票。
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧